Rational design and development of selective BRD7 bromodomain inhibitors and their activity in prostate cancer (original) (raw)

Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors

Ernst Schonbrunn

ACS Chemical Biology, 2014

View PDFchevron_right

Diving into the water: Inducible binding conformations for BRD4, TAF1(2), BRD9, and CECR2 bromodomains

James Audia

Journal of medicinal chemistry, 2016

View PDFchevron_right

The Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition

Anne-Marie Michon

Journal of medicinal chemistry, 2015

View PDFchevron_right

Potent and Selective N-Terminal BRD4 Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement

Huarui Cui

View PDFchevron_right

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

Lucas Vieira

Angewandte Chemie, 2015

View PDFchevron_right

Structural variation of protein-ligand complexes of the first bromodomain of BRD4

Stephen Pickett

View PDFchevron_right

IDENTIFICATION OF POTENT BROMODOMAIN4 (BRD4) INHIBITORS BY ENERGY-PHARMACOPHORE BASED VIRTUAL SCREENING TO TARGET BRD4-NUT MIDLINE CARCINOMA

International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)

International Journal of Pharmacy and Pharmaceutical Sciences, 2015

View PDFchevron_right

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes

Xavier Lucas, Stefan Gerhardt

View PDFchevron_right

In Silico Design and Molecular Basis for the Selectivity of Olinone Towards the First over the Second Bromodomain of BRD4

Yoel Betancourt

Proteins: Structure, Function, and Bioinformatics, 2019

View PDFchevron_right

Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach

santosh adhikari

Organic & biomolecular chemistry, 2018

View PDFchevron_right

Pyronaridine as a Bromodomain-Containing Protein 4-N-Terminal Bromodomain (BRD4-BD1) Inhibitor: In Silico Database Mining, Molecular Docking, and Molecular Dynamics Simulation

Alaa Abdelrahman

Molecules, 2023

View PDFchevron_right

Discovery and characterization of bromodomain 2–specific inhibitors of BRDT

Sureshbabu Nagarajan

Proceedings of the National Academy of Sciences, 2021

View PDFchevron_right

Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor

Jannik Andersen

Journal of Medicinal Chemistry, 2015

View PDFchevron_right

The bromodomain: from epigenome reader to druggable target

Roberto Sanchez

Biochimica et biophysica acta, 2014

View PDFchevron_right

Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells

xiucong bao

Journal of the American Chemical Society, 2019

View PDFchevron_right

4-Acyl Pyrrole Derivatives Yield Novel Vectors for Designing Inhibitors of the Acetyl-Lysine Recognition Site of BRD4(1)

Xavier Lucas, Stefan Gerhardt

View PDFchevron_right

Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit

Gerwyn Bish, Sarah Picaud, Nunzio Sciammetta

Journal of Medicinal Chemistry, 2012

View PDFchevron_right

Controlling Intramolecular Interactions in the Design of Selective, High-Affinity, Ligands for the CREBBP Bromodomain

Kirsten Christensen

View PDFchevron_right

An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains

Kathryn Pugh

Angewandte Chemie International Edition

View PDFchevron_right

Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase–Bromodomain Inhibitor

Huarui Cui

Journal of Medicinal Chemistry

View PDFchevron_right

Selective inhibition of BET bromodomains

Amanda Christie

2010

View PDFchevron_right

A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes

shalil khanal

Journal of Medicinal Chemistry, 2022

View PDFchevron_right

Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations

Ernst Schonbrunn

ACS Omega

View PDFchevron_right

Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy

Talal KHAN

Future Science OA, 2019

View PDFchevron_right

Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability

Alessandra Pasquo

PLOS ONE, 2016

View PDFchevron_right

Potent and selective bivalent inhibitors of BET bromodomains

Michael Waring

Nature Chemical Biology, 2016

View PDFchevron_right

Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains

Ting-Chao Chou

ACS Chemical Biology, 2013

View PDFchevron_right

Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain

Mai Bùi

Journal of Medicinal Chemistry, 2020

View PDFchevron_right

9 H -Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain

Gianluigi Lauro

Journal of Medicinal Chemistry, 2015

View PDFchevron_right

Biased multicomponent reactions to develop novel bromodomain inhibitors

Asha kadam

Journal of medicinal chemistry, 2014

View PDFchevron_right

BET Bromodomain Inhibitors With One-step Synthesis Discovered from Virtual Screen

Norbert Berndt

Journal of medicinal chemistry, 2017

View PDFchevron_right

Structure and acetyl-lysine recognition of the bromodomain

Shiraz Mujtaba

Oncogene, 2007

View PDFchevron_right

Structure-based design of highly selective inhibitors of the CREB binding protein bromodomain

Jotham Coe

Journal of medicinal chemistry, 2017

View PDFchevron_right

Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies

Anne Cheasty

Journal of medicinal chemistry, 2017

View PDFchevron_right